Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | $894K | -$38.2K | -4.1% | Oct 2, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|